Child maltreatment and substance use: associations with alcohol use, nicotine use, and quality of life in a Norwegian population sample
Frontiers in Public Health · 15.05.2026 · 14
DOI: 10.3389/fpubh.2026.1821179 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Public Health, online erschienen am 15.05.2026. Verfasst von Frida Grimsland und 4 weiteren Autor:innen. Beteiligte Einrichtung: Addiction Unit, Sørlandet Hospital Trust, Kristiansand, Norway. Hauptthemen laut MEDLINE: Quality of Life, Alcohol Drinking, Substance-Related Disorders, Tobacco Use. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Child maltreatment (CM) is a significant public health concern with long-term consequences for the child, including an increased likelihood of engaging in risky health behaviors, such as substance use, as well as impaired quality of life (QoL). The relationship between CM and specific substance use patterns, particularly the use of nicotine products such as Swedish snus, remains understudied. We investigated the relationship between CM and the use of nicotine and alcohol, as well as whether use of these substances mediates the association between CM and adulthood QoL.
Methods
This study utilized data from the Norwegian Counties Public Health Survey for Agder in 2023. Latent regression analysis was employed to examine the association between CM and QoL, as well as potential mediated associations involving substance use, while controlling for sociodemographic factors.
Results
Nicotine use in the past year was significantly more prevalent among individuals with a history of CM compared to the group with no history of CM (35.8% vs. 25.6%, p < 0.001). Both smoking (24.3% vs. 15.6%, p < 0.001) and snus use (17.6% vs. 13.3%, p < 0.001) were more common in the CM group, with differences remaining significant after adjustment for sociodemographic factors. No significant differences were found in alcohol use across various measures, including frequency of use, AUDIT-C scores, and binge drinking. Latent regression analysis showed that CM had an overall negative association with QoL [β = −0.61; 95% confidence interval (CI) −0.71, −0.51; p < 0.001]. A significant mediated association involving nicotine use was also observed (β = −0.12; 95% CI −0.16, −0.07; p < 0.001).
Conclusion
CM is associated with a higher prevalence of smoking and snus use, which are negatively associated with QoL. The findings suggest that targeted efforts to support QoL among individuals with a history of CM, including attention to nicotine use, may be relevant within broader strategies addressing living conditions and psychological wellbeing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Addiction Unit, Sørlandet Hospital Trust, Kristiansand, Norway.
- Norwegian Center for Addiction Research (SERAF), University of Oslo, Oslo, Norway.
- Department of Psychosocial Health, University of Agder, Grimstad, Norway.
Zitieren
APA
Grimsland, F., Gabrielsen, K. B., Clausen, T., Haugland, S. H., & Vederhus, J. K. (2026). Child maltreatment and substance use: associations with alcohol use, nicotine use, and quality of life in a Norwegian population sample. Frontiers in Public Health, 14. https://doi.org/10.3389/fpubh.2026.1821179
Vancouver
Grimsland F, Gabrielsen KB, Clausen T, Haugland SH, Vederhus JK. Child maltreatment and substance use: associations with alcohol use, nicotine use, and quality of life in a Norwegian population sample. Frontiers in Public Health. 2026;14. doi:10.3389/fpubh.2026.1821179
BibTeX
@article{Grimsland2026,
author = {Grimsland, Frida and Gabrielsen, Karin Berle and Clausen, Thomas and Haugland, Siri H and Vederhus, John-Kåre},
title = {Child maltreatment and substance use: associations with alcohol use, nicotine use, and quality of life in a Norwegian population sample},
journal = {Frontiers in Public Health},
year = {2026},
volume = {14},
doi = {10.3389/fpubh.2026.1821179}
}
EUVIMED